ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$IMCR:NASDAQ · IMMUNOCORE HLDGS PLC

Sector: health

Conviction from: NASDAQ

52-week range: 27.5040.71

TCR-based cancer immunotherapy biotech (UK)

3 tracked filer(s) hold this · 1 opened, 1 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 67 — mean of 3 scored holder(s) · buyers (new/add) avg 75. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7275New buy15,000,000$13,491,1300.0%
Steve Cohen / Point7275Added +27%1,257,897$38,101,7000.0%
Louis Bacon / Moore52Trimmed -30%193,045$5,847,3330.1%

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.